Targeting cell membrane adaptation as a novel antimicrobial strategy

Area of Science:

• Microbiology
• Bacterial Physiology
• Drug Discovery

Background:

• Antibiotic resistance is a major global health threat, driven by bacterial adaptability.
• Developing new antibiotics against traditional targets is challenging due to limited novel compounds and potential harm to the human microbiota.
• Multidrug-resistant (MDR) bacteria necessitate innovative therapeutic strategies beyond conventional antibiotics.

Purpose of the Study:

• To explore targeting bacterial cell membrane adaptation as a non-traditional approach to combat MDR bacteria.
• To investigate the potential of modulating membrane response to antibiotic attack to resensitize bacteria to existing drugs.
• To evaluate the efficacy of targeting the LiaFSR system in enterococci as a model for enhancing antimicrobial activity and preventing resistance.

Main Methods:

• Review of existing literature on bacterial resistance mechanisms and membrane adaptation.
• Discussion of the LiaFSR regulatory system in enterococci as a model for studying membrane response.
• Conceptual framework for targeting membrane adaptation to potentiate antimicrobial therapies.

Main Results:

• Bacterial membrane adaptation is a key survival mechanism against antibiotic stress.
• Targeting membrane response can potentially increase the efficacy of current antimicrobials.
• Modulating membrane adaptation may enhance the host's innate immune response against bacteria.
• This strategy could prevent the development of antibiotic resistance during treatment.

Conclusions:

• Targeting bacterial membrane adaptation represents a promising non-traditional strategy against MDR pathogens.
• The LiaFSR system serves as a valuable model for understanding and exploiting membrane response pathways.
• This approach offers a potential solution to overcome existing antibiotic limitations and combat resistance.